baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Soc. Generale Call 200 ABBV 21.06.../ DE000SQ4QK64 /

14/05/2024 08:23:00	Chg.0.000	Bid22:00:32	Ask22:00:32	Underlying	Strike price	Expiration date	Option type
0.001EUR	0.00%	- Bid Size: -	- Ask Size: -	AbbVie Inc	200.00 USD	21/06/2024	Call

GlobeNewswire 14/05 CEREVEL THERAPEUTICS HOLDINGS, INC. (NASDAQ: CERE) INVESTIGATION ALERT: Is $45 per CERE Share Enough...

GlobeNewswire 14/05 Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024

GlobeNewswire 14/05 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...

GlobeNewswire 14/05 In NCLA Amicus Win, and FTC Amicus Loss, Second Circuit Upholds Decision Dismissing Antitrust Suit

GlobeNewswire 13/05 Royalty Pharma to Present at Upcoming Investor Conferences

GlobeNewswire 11/05 SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LABP, DOMA, FXNC

GlobeNewswire 09/05 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan

GlobeNewswire 09/05 Royalty Pharma Reports First Quarter 2024 Results

GlobeNewswire 09/05 Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab

GlobeNewswire 09/05 Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of...

GlobeNewswire 08/05 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...

GlobeNewswire 08/05 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 08/05 Alector Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 08/05 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...

GlobeNewswire 08/05 Jnana Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference

GlobeNewswire 08/05 ArriVent BioPharma Reports First Quarter 2024 Financial Results

GlobeNewswire 07/05 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...

GlobeNewswire 07/05 Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 06/05 Pacific Software Inc. Announces a Landmark Asset Acquisition from Dreamaderm Inc.

GlobeNewswire 02/05 Genmab Announces Financial Results for the First Quarter of 2024

GlobeNewswire 02/05 Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer a...

GlobeNewswire 01/05 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...

GlobeNewswire 30/04 CEREVEL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings,...

GlobeNewswire 30/04 U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentratio...

GlobeNewswire 25/04 Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024

Soc. Generale Call 200 ABBV 21.06.../ DE000SQ4QK64 /

If you wish to receive reply to your feedback, please provide your email address.